241 related articles for article (PubMed ID: 6087399)
21. Calcitriol-mediated hypercalcaemia and increased interleukins in a patient with sarcoid myopathy.
Peris P; Font J; Grau JM; Martínez de Osaba MJ; Filella X; Muñoz-Gómez J
Clin Rheumatol; 1999; 18(6):488-91. PubMed ID: 10638776
[TBL] [Abstract][Full Text] [Related]
22. Vitamin D3 metabolites in hypercalcaemic adults after kidney transplantation.
Lucas PA; Brown RC; Bloodworth L; Woodhead JS
Proc Eur Dial Transplant Assoc; 1983; 20():213-9. PubMed ID: 6318219
[TBL] [Abstract][Full Text] [Related]
23. Seasonal variation in serum 25-hydroxy vitamin D3 does not affect 1,25-dihydroxy vitamin D.
Hine TJ; Roberts NB
Ann Clin Biochem; 1994 Jan; 31 ( Pt 1)():31-4. PubMed ID: 8154850
[TBL] [Abstract][Full Text] [Related]
24. Long-term effects of 1,25-dihydroxy vitamin D3 and 24,25-dihydroxy vitamin D3 in renal osteodystrophy.
Muirhead N; Adami S; Sandler LM; Fraser RA; Catto GR; Edward N; O'Riordan JL
Q J Med; 1982; 51(204):427-44. PubMed ID: 6760236
[TBL] [Abstract][Full Text] [Related]
25. Calcaemic responses in the yellow monitor, varanus flavescens to vitamin D3 administration.
Swarup K; Pandey AK; Srivastav AK
Acta Physiol Hung; 1987; 70(4):375-7. PubMed ID: 2830765
[TBL] [Abstract][Full Text] [Related]
26. [Efficiency of calcium and vitamin D3 in the treatment of steroid osteoporosis in patients with hormone dependent bronchial asthma].
Ememl'ianov AV; Shevelev SE; Murzin BA; Amosov VI
Ter Arkh; 1999; 71(11):68-9. PubMed ID: 10626343
[TBL] [Abstract][Full Text] [Related]
27. Ketoconazole reduces elevated serum levels of 1,25-dihydroxyvitamin D in hypercalcemic sarcoidosis.
Glass AR; Cerletty JM; Elliott W; Lemann J; Gray RW; Eil C
J Endocrinol Invest; 1990 May; 13(5):407-13. PubMed ID: 2166103
[TBL] [Abstract][Full Text] [Related]
28. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
29. Calcium and vitamin D in sarcoidosis: is supplementation safe?
Kamphuis LS; Bonte-Mineur F; van Laar JA; van Hagen PM; van Daele PL
J Bone Miner Res; 2014 Nov; 29(11):2498-503. PubMed ID: 24753153
[TBL] [Abstract][Full Text] [Related]
30. Recent clinical trials of vitamin D3 supplementation and serum calcium levels in humans: Implications for vitamin D-based chemoprevention.
Skinner HG; Litzelman K; Schwartz GG
Curr Opin Investig Drugs; 2010 Jun; 11(6):678-87. PubMed ID: 20496263
[TBL] [Abstract][Full Text] [Related]
31. Hypercalcemia of sarcoidosis treated with cellulose sodium phosphate.
Dwarakanathan A; Ryan WG
Bone Miner; 1987 Jul; 2(4):333-6. PubMed ID: 2851338
[TBL] [Abstract][Full Text] [Related]
32. 1, 25-dihydroxycholecalciferol in the pathogenesis of the hypercalcaemia of sarcoidosis.
Papapoulos SE; Clemens TL; Fraher LJ; Lewin IG; Sandler LM; O'Riordan JL
Lancet; 1979 Mar; 1(8117):627-30. PubMed ID: 85869
[TBL] [Abstract][Full Text] [Related]
33. Hypercalcemia worsened after vitamin D supplementation in a sarcoidosis patient: A case report.
Mio K; Haruhara K; Shimizu A; Oshiro K; Kawai R; Ikeda M; Yokoo T
Medicine (Baltimore); 2022 Oct; 101(40):e30883. PubMed ID: 36221396
[TBL] [Abstract][Full Text] [Related]
34. A Phase I trial of calcitriol (1,25-dihydroxycholecalciferol) in patients with advanced malignancy.
Smith DC; Johnson CS; Freeman CC; Muindi J; Wilson JW; Trump DL
Clin Cancer Res; 1999 Jun; 5(6):1339-45. PubMed ID: 10389917
[TBL] [Abstract][Full Text] [Related]
35. Sarcoidosis-related hypercalcaemia due to production of parathyroid hormone-related peptide.
van Raalte DH; Goorden SM; Kemper EA; Brosens LA; ten Kate RW
BMJ Case Rep; 2015 Jul; 2015():. PubMed ID: 26160550
[TBL] [Abstract][Full Text] [Related]
36. Chronotherapy of high-dose 1,25-dihydroxyvitamin D3 in hemodialysis patients with secondary hyperparathyroidism: a single-dose study.
Tsuruoka S; Sugimoto K; Ohmori M; Kawaguchi A; Saito T; Fujimura A
Clin Pharmacol Ther; 1999 Dec; 66(6):609-16. PubMed ID: 10613617
[TBL] [Abstract][Full Text] [Related]
37. Hypercalcaemia due to sarcoidosis corrects with bisphosphonate treatment.
Gibbs CJ; Peacock M
Postgrad Med J; 1986 Oct; 62(732):937-8. PubMed ID: 3774726
[TBL] [Abstract][Full Text] [Related]
38. Ketoconazole decreases the serum 1,25-dihydroxyvitamin D and calcium concentration in sarcoidosis-associated hypercalcemia.
Adams JS; Sharma OP; Diz MM; Endres DB
J Clin Endocrinol Metab; 1990 Apr; 70(4):1090-5. PubMed ID: 2318934
[TBL] [Abstract][Full Text] [Related]
39. Radioimmunoassay of 1,25-dihydroxy vitamin D2: studies on the metabolism of vitamin D2 in man.
Fraher LJ; Adami S; Clemens TL; Jones G; O'Riordan JL
Clin Endocrinol (Oxf); 1983 Aug; 19(2):151-65. PubMed ID: 6603929
[TBL] [Abstract][Full Text] [Related]
40. Rapid effect of prednisolone on serum 1,25-dihydroxycholecalciferol levels in hypercalcemic sarcoidosis.
Nordal KP; Dahl E; Halse J; Aksnes L; Aarskog D
Acta Med Scand; 1985; 218(5):519-23. PubMed ID: 3841460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
